Skip to main content
    F

    FibroBiologics, Inc. Common Stock (FBLG)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.90
    -0.02 (-2.56%)

    Market Cap: $6.57M

    Last updated: Nov 17, 2026 at 11:01 AM ET

    FibroBiologics, Inc. Common Stock (FBLG) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect FibroBiologics, Inc. Common Stock (FBLG) to earn -$3.00 per share in the fiscal year ending Dec 31, 2026. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$3.25.

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    Fiscal year ending Dec 31, 2026
    -$3.00
    EPS consensus
    Fiscal year ending Dec 31, 2027
    -$3.25
    EPS consensus
    Next report
    Feb 22, 2027
    Estimated

    EPS range

    Fiscal year endingEPS consensusEPS rangeEPS analysts
    Dec 31, 2026-$3.00-$3.00 to -$3.001
    Dec 31, 2027-$3.25-$3.25 to -$3.251

    Quarterly Estimates

    Quarter endingEPS consensusEPS rangeEPS analysts
    Dec 31, 2026-$0.64N/A3

    Estimate Revisions

    Across the 2 periods below, the last 30 days brought 2 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202610
    Fiscal year ending Dec 31, 202710

    EPS Trend

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$3.00-$4.01-$4.01-$4.01-$3.71N/A
    Fiscal year ending Dec 31, 2027-$3.25-$4.49-$4.49-$4.49-$3.85N/A

    Frequently Asked Questions About FBLG

    What is the FBLG stock forecast?

    Consensus analyst estimates put FibroBiologics, Inc. Common Stock's EPS at -$3.00 for the fiscal year ending Dec 31, 2026.

    What EPS do analysts expect from FBLG next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$3.00, with estimates from -$3.00 to -$3.00 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$3.25, with estimates from -$3.25 to -$3.25 from 1 analyst.

    How many analysts cover FBLG?

    1 analyst estimates EPS for FibroBiologics, Inc. Common Stock for the fiscal year ending Dec 31, 2026.